Agilent Technologies
Open
$112.99
Prev. Close
$112.93
High
$113.47
Low
$112.99
Market Snapshot
$31.55B
24.5
4.44
$6.51B
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
emptyResult
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Recently from Cashu

Agilent Technologies Faces Patent Rulings While Launching New Research Technology Amid Legal Challenges
Agilent Technologies (A) faces a significant legal challenge as the United States Supreme Court upholds rulings that invalidate its patents associated with the CRISPR gene-editing technology. This piv…
Insider Purchases Signal Confidence in Agilent Technologies' Future Prospects and Innovation
Confidence in Innovation: Insider Share Purchases at Agilent Technologies In a significant show of confidence, Agilent Technologies (NYSE:A) experiences notable insider purchases from its directors, s…
Agilent Technologies Advances Precision Medicine with Innovative Tools and Collaborative Efforts
Agilent Technologies Enhances Its Capabilities in Precision Medicine Agilent Technologies continues to strengthen its position within the rapidly evolving landscape of precision medicine, signifying a…
Agilent Technologies Enhances Biotech Sector with New Advanced Genomic Solutions
Agilent Technologies Expands Commitment to Biotech by Launching New Genomic Solutions In a significant move aimed at enhancing its footprint in the biotechnology sector, Agilent Technologies recently…